We studied intracellular calcium mobilization, CD3/CD28-triggered activation of ZAP-70, PKC-θ, and MAPKs in cells of TBP patients at baseline and after 6 months of treatment. This evidence concerns the gene PRRT2 and total blood protein measurement.